131 related articles for article (PubMed ID: 2128757)
1. The differential activities of R (+)- and S(-)-zacopride as 5-HT3 receptor antagonists.
Barnes JM; Barnes NM; Costall B; Domeney AM; Johnson DN; Kelly ME; Munson HR; Naylor RJ; Young R
Pharmacol Biochem Behav; 1990 Dec; 37(4):717-27. PubMed ID: 2128757
[TBL] [Abstract][Full Text] [Related]
2. The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.
Waeber C; Pinkus LM; Palacios JM
Eur J Pharmacol; 1990 Jun; 181(3):283-7. PubMed ID: 2384135
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
Kidd FJ; Levy JC; Nielsen M; Hamon M; Gozlan H
Eur J Pharmacol; 1993 Sep; 247(1):45-56. PubMed ID: 8258360
[TBL] [Abstract][Full Text] [Related]
4. The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour.
Barnes NM; Costall B; Ge J; Kelly ME; Naylor RJ
Eur J Pharmacol; 1992 Jul; 218(1):15-25. PubMed ID: 1356806
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
[TBL] [Abstract][Full Text] [Related]
6. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
Barnes JM; Barnes NM
Biochem Pharmacol; 1993 May; 45(10):2155-8. PubMed ID: 8390263
[TBL] [Abstract][Full Text] [Related]
7. The potent 5-HT3 receptor antagonist (R)-zacopride labels an additional high affinity site in the central nervous system.
Kidd E; Bouchelet de Vendegies I; Levy JC; Hamon M; Gozlan H
Eur J Pharmacol; 1992 Jan; 211(1):133-6. PubMed ID: 1618262
[TBL] [Abstract][Full Text] [Related]
8. Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model.
Barnes NM; Cheng CH; Costall B; Ge J; Kelly ME; Naylor RJ
Eur J Pharmacol; 1992 Jul; 218(1):91-100. PubMed ID: 1356807
[TBL] [Abstract][Full Text] [Related]
9. Zacopride: anxiolytic profile in rodent and primate models of anxiety.
Costall B; Domeney AM; Gerrard PA; Kelly ME; Naylor RJ
J Pharm Pharmacol; 1988 Apr; 40(4):302-5. PubMed ID: 2900320
[TBL] [Abstract][Full Text] [Related]
10. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
Wade PR; Mawe GM; Branchek TA; Gershon MD
Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
[TBL] [Abstract][Full Text] [Related]
11. Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.
Barnes JM; Barnes NM; Champaneria S; Costall B; Naylor RJ
Neuropharmacology; 1990 Nov; 29(11):1037-45. PubMed ID: 2087255
[TBL] [Abstract][Full Text] [Related]
12. Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.
Bolaños FJ; Schechter LE; Miquel MC; Emerit MB; Rumigny JF; Hamon M; Gozlan H
Biochem Pharmacol; 1990 Oct; 40(7):1541-50. PubMed ID: 2222509
[TBL] [Abstract][Full Text] [Related]
13. 5-HT3 receptor antagonists attenuate dopamine-induced hyperactivity in the rat.
Costall B; Domeney AM; Naylor RJ
Neuroreport; 1990 Sep; 1(1):77-80. PubMed ID: 1966601
[TBL] [Abstract][Full Text] [Related]
14. Zacopride and its optical isomers produce stereoselective antagonism of a 2-methylserotonin discriminative stimulus.
Young R; Glennon RA
Eur J Pharmacol; 1992 Feb; 212(1):117-9. PubMed ID: 1555633
[TBL] [Abstract][Full Text] [Related]
15. [(125I)iodo-zacopride: new ligand for the study by autoradiography of central 5-HT3 receptors].
Koscielniak T; Ponchant M; Laporte AM; Guminski Y; Verge D; Hamon M; Gozlan H
C R Acad Sci III; 1990; 311(6):231-7. PubMed ID: 2121314
[TBL] [Abstract][Full Text] [Related]
16. Zacopride, a potent 5-HT3 antagonist.
Smith WW; Sancilio LF; Owera-Atepo JB; Naylor RJ; Lambert L
J Pharm Pharmacol; 1988 Apr; 40(4):301-2. PubMed ID: 2900319
[TBL] [Abstract][Full Text] [Related]
17. Comparison of potencies of 5-HT3 receptor antagonists at inhibiting aversive behavior to illumination and the von Bezold-Jarisch reflex in the mouse.
Eglen RM; Lee CH; Khabbaz M; Fontana DJ; Daniels S; Kilfoil T; Wong EH
Neuropharmacology; 1994 Feb; 33(2):227-34. PubMed ID: 8035908
[TBL] [Abstract][Full Text] [Related]
18. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
Barnes NM; Costall B; Naylor RJ
J Pharm Pharmacol; 1988 Aug; 40(8):548-51. PubMed ID: 2907008
[TBL] [Abstract][Full Text] [Related]
19. Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands.
Laporte AM; Koscielniak T; Ponchant M; Vergé D; Hamon M; Gozlan H
Synapse; 1992 Apr; 10(4):271-81. PubMed ID: 1585260
[TBL] [Abstract][Full Text] [Related]
20. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
Middlefell VC; Price TL
Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
